Israel’s Rabin medical center has established the only special clinic in israel to perform genetic screening to treat and prevent cancer. The BRCA Multidisciplinary Clinic was created to serve patients with a high risk of cancer at Rabin Medical Center’s Davidoff Cancer Center. Since its commencement in 2011, the clinic has served thou - sands of women. Women who carry the BRCA gene mutation have up to an 80% chance of developing breast and/or ovarian cancer. More than 200 mutations have been identi - fied, three of which are typical to Ashkenazi Jews. There is a 2.5% risk of carrying this mutation. One out of every forty Jewish Ashkenazi women is a carrier and has a high probability of developing ovarian and/or breast cancer. At the Rabin Medical Center BRCA Clinic, patients receive counseling, screening and follow-up care. With breast cancer at such a high rate in Israel, affecting about 31% of women suffering from malignant dis eases, the BRCA Multidisciplinary Clinic is essential to saving lives.
The BRCA Multidisciplinary Clinic also treats men with prostate cancer. Research data indicates that men carry mutations in the BRCA 1 and 2 genes, similar to the syn - drome for breast and ovarian cancer in women. Three thousand new cases of prostate cancer are diagnosed in Israel annually, with four hundred fatalities.
IDF Chief of Staff Lt. Gen. Gadi Eisenkot was released from Rabin Medical Center on Saturday [Jan. 21], after doctors removed a cancerous growth from his prostate earlier this week, the army said.
A researcher at Zebra Medical Vision has created a new mammography algorithm that uses machine and deep learning to diagnose breast cancer (BC), with results that the company claims are superior to those achieved using current methods.